FrancophonIA/ELRC3.0 huggingface dataset:
English: A small transient swelling at the site of injection (≤ 4 cm), which can occasionally be firm and painful on palpation, has been observed very commonly in clinical studies.
Croatian: Mala prolazna oteklina na mjestu injekcije (≤ 4 cm), koja se često pojavljivala u kliničkim ispitivanjima, ponekad može biti tvrda i bolna na dodir.
English: SPECIAL WARNING(S)
Croatian: 12. POSEBNO(A) UPOZORENJE(A)
English: Plastic box with 5, 10, 25 or 50 vials of 1 ml Cardboard box with 1 vial of 10 ml
Croatian: Plastična kutija s 5, 10, 25 ili 50 bočica od 1ml Kartonska kutija s 1 bočicom od 10 ml
English: When mixed with Nobivac vaccines containing canine parainfluenza virus at annual revaccination, it has been established that there is no interference with the anamnestic response induced by the injectable canine parainfluenza virus component.
Croatian: Kada se pomiješa s Nobivac cjepivima koji sadrže virus parainfluence kod godišnje revakcinacije, dokazano je da nema interferencije s anamnestičkim odgovorom induciranim s injekcijskom komponentom virusa pseće parainfluence.
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT
Croatian: NAZIV I ADRESA NOSITELJA ODOBRENJA ZA STAVLJANJE U PROMET I NOSITELJA ODOBRENJA ZA PROIZVODNJU ODGOVORNOG ZA PUŠTANJE PROIZVODNE SERIJE, AKO JE RAZLIČITO
English: Plastic box with 5, 10, 25 or 50 vials of 1 ml (1 dose).
Croatian: Plastična kutija s 5, 10, 25 ili 50 bočica od 1 ml (1 doza).
English: For example, local swelling, which can be up to 5 cm in diameter and which may take over 5 weeks to completely disappear, may be observed at the site of injection.
Croatian: Na primjer, na mjestu aplikacije vakcine može se pojaviti oteklina, promjera do 5 cm, a do njenog potpunog nestanka može proći više od 5 tjedana.
English: Intervet International B.V. Wim de Körverstraat 35 5831 AN Boxmeer The NETHERLANDS
Croatian: Wim de Körverstraat 35 NL - 5831 AN Boxmeer NIZOZEMSKA
English: Subcutaneous use.
Croatian: Subkutana primjena.
English: MANUFACTURER'S BATCH NUMBER Lot {number}
Croatian: 17. BROJ PROIZVODNE SERIJE PROIZVOĐAČA
English: MARKETING AUTHORISATION HOLDER
Croatian: NOSITELJ ODOBRENJA ZA STAVLJANJE U PROMET
English: For animal treatment only.
Croatian: Samo za primjenu na životinjama.
English: Vaccination scheme: Basic vaccination: The first vaccination can be administered from 6 to 9(*) weeks of age and the second vaccination from 10 to 13 weeks of age.
Croatian: Osnovno cijepljenje: prvo cijepljenje u dobi 6 do 9(*) tjedana, a drugo cijepljenje u dobi od 10 do 13 tjedana starosti.
English: Shelf life after reconstitution of Nobivac vaccines according to directions: 45 mins.
Croatian: Rok valjanosti vakcine Nobivac poslije rekonstitucije prema uputi: 45 minuta.
English: Do not use this veterinary medicinal product after the expiry date which is stated on the label.
Croatian: Ne koristiti poslije isteka roka valjanosti naznačenog na etiketi.
English: Incompatibilities: Do not mix with any other veterinary medicinal products except the above mentioned vaccines.
Croatian: Ne miješati s bilo kojim drugim veterinarsko-medicinskim proizvodom, osim s gore navedenim vakcinama.
English: PHARMACEUTICAL FORM Suspension for injection.
Croatian: Suspenzija za injekciju.
English: Pack sizes:
Croatian: Pakovanje:
English: For active immunisation of dogs against: - L. interrogans serogroup Canicola serovar Canicola to reduce infection and urinary excretion - L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni to reduce infection and urinary excretion - L. interrogans serogroup Australis serovar Bratislava to reduce infection - L. kirschneri serogroup Grippotyphosa serovar Bananal/Lianguang to reduce infection and urinary excretion.
Croatian: Za aktivnu imunizaciju pasa protiv: - L. interrogans, serogrupa Canicola, serovar Canicola, za smanjenje infekcije i izlučivanja putem urina, - L. interrogans, serogoupa Icterohaemorrhagiae, serovar Copenhagen, za smanjenje infekcije i izlučivanja putem urina, - L. interrogans, serogrupa Australis, serovar Bratislava, za smanjenje infekcije, - L. kirschneri, serogrupa Grippotyphosa, serovar Bananal/Lianguang, za smanjenje infekcije i izlučivanja putem urina.
English: 6.4 Special precautions for storage
Croatian: 6.4 Posebne mjere predostrožnosti za čuvanje
English: In vitro and in vivo data in non-target species suggests that the vaccine may provide a degree of crossprotection against L. interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagiae and L. kirschneri serogroup Grippotyphosa serovar Grippotyphosa.
Croatian: In vitro i in vivo podaci ukazuju da cjepivo, u neciljnih vrsta životinja, može pružiti određeni stupanj unakrižne zaštite protiv L. interrogans, serogroupa Icterohaemorrhagiae, soj Icterohaemorrhagiae i L. kirschneri, serogroupa Grippotyphosa, soj Grippotyphosa.
English: SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY
Croatian: 13. POSEBNE MJERE PREDOSTROŽNOSTI ZA ODLAGANJE NEUPOTREBLJENOG PROIZVODA ILI OTPADNIH MATERIJALA, AKO IH IMA
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains:
Croatian: Svaka doza od 1 ml sadrži
English: - L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni (strain Ic-02-001)
Croatian: - L. interrogans, serogrupa Icterohaemorrhagiae, serovar Copenhageni
English: 4.1 Target species
Croatian: KLINIČKE POJEDINOSTI 4.1 Ciljne vrste životinja
English: 4.5 Special precautions for use
Croatian: 4.5 Posebne mjere predostrožnost za primjenu
English: Sodium chloride Potassium chloride Disodium phosphate dihydrate Potassium dihydrogen phosphate
Croatian: Dinatrij fosfat dihidrat
English: Marketing authorisation holder and manufacturer responsible for batch release:
Croatian: Nositelj odobrenja za stavljanje u promet i proizvođač odgovoran za puštanje serije u promet:
English: Safety and efficacy data are available which demonstrate that this vaccine can be administered on the same day but not mixed with vaccines of the Nobivac series containing Bordetella bronchiseptica and/or parainfluenza virus components for intranasal administration.
Croatian: Dostupni podaci o neškodljivosti i djelotvornosti dokazuju da ovo cjepivo smije biti primijenjeno istoga dana, ali ne pomiješano s cjepivima iz serije Nobivac, koja sadrže Bordetella bronchiseptica i/ili parainfluenca virusne komponente, za intranazalnu primjenu.
English: SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCTS OR WASTE MATERIALS, IF ANY
Croatian: 12. POSEBNE MJERE PREDOSTROŽNOSTI ZA ODLAGANJE NEUPOTREBLJENIH PROIZVODA ILI OTPADNIH MATERIJALA, AKO IH IMA
English: A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCES AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
Croatian: PROIZVOĐAČ BIOLOŠKI DJELATNIH TVARI I PROIZVOĐAČ ODGOVORAN ZA PUŠTANJE SERIJE U PROMET
English: To stimulate active immunity in dogs against L. interrogans serogroup Canicola serovar Canicola, L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni, L. interrogans serogroup Australis serovar Bratislava, and L. kirschneri serogroup Grippotyphosa serovar Bananal/Lianguang.
Croatian: Cjepivo potiče aktivnu imunost u pasa protiv L. interrogans, serogrupa Canicola, serovar Canicola, L. interrogans, serogrupa Icterohaemorrhagiae, serovar Copenhageni, L. interrogans, serogrupa Australis, serovar Bratislava i L. kirschneri, serogrupa Grippotyphosa, serovar Bananal/Lianguang.
English: PHARMACEUTICAL FORM Suspension for injection
Croatian: Suspenzija za injekciju
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
Croatian: 15. NAZIV I ADRESA NOSITELJA ODOBRENJA ZA STAVLJANJE U PROMET
English: Vial of 1 ml or 10 ml
Croatian: Bočica od 1 ml i 10 ml
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Nobivac L4 suspension for injection for dogs
Croatian: UPUTA O VMP Nobivac L4 suspenzija za injekciju za pse
English: STATEMENT OF ACTIVE SUBSTANCES Read the package leaflet before use.
Croatian: NAVOĐENJE DJELATNIH TVARI Pročitati uputu prije primjene.
English: For simultaneous use, 1 dose of a Nobivac vaccine containing canine distemper virus, canine adenovirus type 2, canine parvovirus and/or canine parainfluenza virus components should be reconstituted with 1 dose (1 ml) of Nobivac L4.
Croatian: Za istodobnu primjenu, 1 dozu cjepiva Nobivac koja sadrži komponente virusa štenećaka, psećeg adenovirusa tip 2, psećeg parvovirusa i/ili psećeg virusa parainfluence treba otopiti s 1 dozom (1 ml) Nobivac L4.
English: Special precautions for use in animals Not applicable.
Croatian: Posebne mjere predostrožnost za primjenu na životinjama
English: Read the package leaflet before use.
Croatian: Pročitati uputu o VMP prije primjene.
English: Excipient:
Croatian: Djelatna tvar:
English: - L. interrogans serogroup Australis serovar Bratislava (strain As-05-073)
Croatian: (soj Ic-02-001) - L. interrogans, serogrupa Australis, serovar Bratislava (soj As-05-073)
English: PACKAGE LEAFLET: Nobivac L4 suspension for injection for dogs
Croatian: Nobivac L4, suspenzija za injekciju za pse
English: BATCH NUMBER Lot {number}
Croatian: Lot {broj}
English: CLINICAL PARTICULARS
Croatian: Kalijev klorid
English: Overdose (symptoms, emergency procedures, antidotes):
Croatian: Predoziranje (simptomi, hitni postupci, antidoti): Nakon primjene dvostruke doze nisu uočene neželjene pojave osim onih navedenih u odjeljku 6.
English: SPECIAL WARNING(S), IF NECESSARY Read the package leaflet before use.
Croatian: POSEBNA UPOZORENJA, UKOLIKO JE POTREBNO
English: Administer two vaccinations of 1 dose (1 ml) of vaccine with an interval of 4 weeks to dogs from 6 weeks of age onwards.
Croatian: Pse u dobi od 6 tjedana i više cijepiti dva puta s 1 dozom (1 ml) cjepiva, u razmaku od 4 tjedna.
English: Safety and efficacy data are available which demonstrate that this vaccine can be mixed and administered with vaccines of the Nobivac series containing canine distemper virus, canine adenovirus type 2, canine parvovirus and/or canine parainfluenza virus components for subcutaneous administration.
Croatian: Dostupni podaci o neškodljivosti i djelotvornosti dokazuju da se ovo cjepivo smije pomiješati i upotrebljavati s cjepivima iz serije Nobivac koja sadrže komponente virusa štenećaka, psećeg adenovirusa tip 2, psećeg parvovirusa i/ili psećeg virusa parainfluence, za subkutanu primjenu.
English: Special warnings for each target species: Vaccinate healthy animals only.
Croatian: Posebna upozorenja za svaku od ciljnih vrsta:
English: ANNEX III LABELLING AND PACKAGE LEAFLET
Croatian: OZNAČAVANJE I UPUTA O VMP
English: Name and address of the manufacturer responsible for batch release
Croatian: Naziv i adresa proizvođača odgovornog za puštanje serije u promet Intervet International BV
English: QUANTITY OF THE ACTIVE SUBSTANCE(S) See package leaflet.
Croatian: KOLIČINA DJELATNIH I DRUGIH TVARI Vidi uputu.
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Nobivac L4
Croatian: Nobivac L4
English: 4.9 Amounts to be administered and administration route
Croatian: 4.9 Količine koje se primjenjuju i način primjene Subkutana primjena.
English: MARKETING AUTHORISATION NUMBER(S)
Croatian: BROJ(EVI) ODOBRENJA ZA STAVLJANJE U PROMET
English: 4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
Croatian: 4.10 Predoziranje (simptomi, hitni postupci, antidoti), ako je nužno Nakon primjene dvostruke doze nisu uočene neželjene pojave osim navedenih u odjeljku 4.6. Ipak, ove reakcije mogu biti izraženije i/ili trajati dulje.
English: MANUFACTURER RESPONSIBLE FOR BATCH RELEASE B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE C. STATEMENT OF THE MRLs
Croatian: UVJETI ILI OGRANIČENJA U POGLEDU OPSKRBE I PRIMJENE
English: 4.11 Withdrawal period
Croatian: 4.11 Karencija
English: Active substances:
Croatian: Program cijepljenja:
English: (just for 10 ml vials)
Croatian: 10 ml (10 doza)
English: EXPIRY DATE
Croatian: PUT(EVI) PRIMJENE
English: 6.3 Shelf life
Croatian: Intervet International BV
English: 24 June 2016
Croatian: 24. lipnja 2016.
English: Ask your pharmacist how to throw away medicines you no longer require.
Croatian: Pitajte svog ljekarnika kako baciti lijekove koji Vam više nisu potrebni.
English: Elderly patients (≥65 years)
Croatian: Stariji bolesnici (≥ 65 godina)
English: • bad taste in your mouth
Croatian: • neugodan okus u ustima
English: Reconstitution time is less than 2 minutes.
Croatian: Vrijeme rekonstitucije iznosi manje od 2 minute.
English: This reaction may be life-threatening.
Croatian: Takva reakcija može biti opasna po život.
English: A course of treatment usually lasts from 5 to up to 14 days, depending on the type of infection you have and how you respond to treatment.
Croatian: Jedan ciklus liječenja obično traje od 5 do 14 dana, ovisno o vrsti infekcije koju imate i kako odgovarate na liječenje.
English: These show how well your kidneys are working.
Croatian: One pokazuju koliko dobro Vam rade bubrezi.
English: It can kill many types of bacteria.
Croatian: Može uništiti brojne vrste bakterija.
English: A risk to newborns/infants cannot be excluded.
Croatian: Ne može se isključiti rizik za novorođenče/dojenče.
English: Uncommon Very rare
Croatian: Manje često Vrlo rijetko
English: Paediatric population Safety and efficacy in children and adolescents below 18 years of age have not yet been established.
Croatian: Pedijatrijska populacija Sigurnost i djelotvornost u djece i adolescenata mlađih od 18 godina nisu još ustanovljene.
English: Zavicefta should not be used in children and adolescents .
Croatian: Zavicefta se ne smije koristiti u djece i adolescenata.
English: Other types of interaction
Croatian: Druge vrste interakcija
English: Currently available data are described in section 4.8 but no recommendation on a posology can be made.
Croatian: Trenutno dostupni podaci opisani su u dijelu 4.8 međutim nije moguće dati preporuku o doziranju.
English: Other infections
Croatian: Druge infekcije
English: Every 8 hours
Croatian: Svakih 8 sati
English: • swelling under the skin, particularly lips and around the eyes
Croatian: • oticanje ispod kože, osobito usana i područja oko očiju
English: Clinical efficacy against specific pathogens
Croatian: Klinička djelotvornost protiv specifičnih patogena
English: Unknown (cannot be estimated from the available data)
Croatian: Nepoznato: (učestalost se ne može procijeniti iz dostupnih podataka)
English: Serious and occasionally fatal hypersensitivity reactions are possible (see sections 4.3 and 4.8).
Croatian: Moguće su ozbiljne i ponekad smrtonosne reakcije preosjetljivosti (vidjeti dijelove 4.3 i 4.8).
English: CrCL estimated using the Cockcroft-Gault formula
Croatian: CrCl procijenjen pomoću Cockcroft-Gaultove formule
English: Zavicefta is used in adults to treat:
Croatian: Zavicefta se koristi u odraslih za liječenje:
English: • infections caused by bacteria that other antibiotics may not be able to kill
Croatian: • infekcija uzrokovanih bakterijama koje drugi antibiotici možda ne mogu uništiti
English: Very rare: (may affect up to 1 in 10,000 people) • swelling in a part of the kidney that causes a reduction in its normal working function
Croatian: Vrlo rijetko: (mogu se javiti u manje od 1 na 10 000 osoba) • oticanje jednog dijela bubrega koje uzrokuje smanjenje njegove normalne funkcije
English: Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Croatian: Potrebno je uzeti u obzir službene smjernice o primjerenoj uporabi antibakterijskih lijekova.
English: • severe allergic reaction (see Serious side effects, above)
Croatian: • teška alergijska reakcija (pogledajte Ozbiljne nuspojave u tekstu iznad)
English: 2 hours
Croatian: 2 sata
English: If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine.
Croatian: Ako ste trudni ili dojite, mislite da biste mogli biti trudni ili planirate imati dijete, obratite se svom liječniku za savjet prije nego primite ovaj lijek.
English: If this happens do not take medicines that stop or slow bowel movement.
Croatian: Ako se to dogodi, ne smijete uzimati lijekove koji zaustavljaju ili usporavaju rad crijeva.
English: Once removed from refrigeration to room temperature, the diluted product must be used within 12 hours.
Croatian: Nakon što se izvadi iz hladnjaka na sobnu temperaturu, razrijeđeni lijek mora se primijeniti unutar 12 sati.
English: Duration of treatment
Croatian: Trajanje liječenja
English: Talk to your pharmacist or doctor if you have been advised to have a low salt diet.
Croatian: Obratite se svom ljekarniku ili liječniku ako Vam je preporučena prehrana s niskim udjelom soli.
English: Patients with CrCL 30 to 50 mL/min received a lower dose of Zavicefta than is currently recommended for patients in this sub-group.
Croatian: Bolesnici s CrCl od 30 do 50 ml/min primili su nižu dozu lijeka Zavicefta nego što je trenutno preporučeno za bolesnike u ovoj podskupini.
English: Each vial is for single use only.
Croatian: Jedna bočica namijenjena je samo za jednokratnu uporabu.
English: In seven Phase 2 and Phase 3 clinical trials, 2024 adult patients were treated with Zavicefta.
Croatian: U sedam kliničkih ispitivanja faze 2 i faze 3, 2024 odraslih bolesnika bilo je liječeno lijekom Zavicefta.
English: Amount to be withdrawn
Croatian: Količina koju treba izvući
English: • severe allergic reactions - signs include sudden swelling of your lips, face, throat or tongue, a severe rash or other severe skin reactions, difficulty swallowing or breathing.
Croatian: • teške alergijske reakcije - znakovi uključuju iznenadno oticanje usana, lica, grla ili jezika, težak osip ili druge teške kožne reakcije, otežano gutanje ili otežano disanje.
English: The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of European Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines webportal.
Croatian: Zahtjevi za podnošenje periodičkih izvješća o neškodljivosti za ovaj lijek definirani su u referentnom popisu datuma EU (EURD popis) predviđenom člankom 107.c stavkom 7. Direktive 2001/83/EZ i svim sljedećim ažuriranim verzijama objavljenima na europskom internetskom portalu za lijekove.
English: Ceftazidime/avibactam should only be used during pregnancy if the potential benefit outweighs the possible risk.
Croatian: Ceftazidim/avibaktam se tijekom trudnoće smije primjenjivati samo ako moguća korist nadmašuje mogući rizik.
English: Limitations of the clinical data
Croatian: Ograničenja kliničkih podataka
English: If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user.
Croatian: Ako se ne primijeni odmah, vrijeme i uvjeti čuvanja do primjene lijeka odgovornost su korisnika.
English: Mix gently to reconstitute and check to see that the contents have dissolved completely.
Croatian: Nježno miješajte otopinu da biste je rekonstituirali i provjerite je li se sadržaj u potpunosti otopio.
English: Tell your doctor straight away if you notice any of the following serious side effects - you may need urgent medical treatment:
Croatian: Odmah se obratite svom liječniku ako se pojavi bilo koja od sljedećih ozbiljnih nuspojava - možda će Vam biti potrebno hitno liječenje:
English: Patients with limited treatment options
Croatian: Bolesnici s ograničenim mogućnostima liječenja
English: The powder must be reconstituted with water for injections and the resulting concentrate must then be immediately diluted prior to use.
Croatian: Prašak se mora rekonstituirati vodom za injekcije, a dobiveni koncentrat se zatim mora odmah razrijediti prije primjene.
English: From a microbiological point of view, the medicinal product should be used immediately.
Croatian: S mikrobiološkog stanovišta, lijek se mora odmah primijeniti.
English: It is possible that this could cause anaemia (which may make you feel tired) and jaundice (yellowing of the skin and eyes)
Croatian: To može uzrokovati anemiju (zbog koje se možete osjećati umorno) i žuticu (žuta boja kože i očiju).
English: • you have kidney problems - your doctor may give you a lower dose to make sure you don't get too much medicine.
Croatian: • ako imate bubrežnih tegoba - liječnik će Vam možda dati nižu dozu kako bi osigurao da ne dobijete previše lijeka.
English: The compatibility of Zavicefta with other medicines has not been established.
Croatian: Kompatibilnost lijeka Zavicefta s drugim lijekovima nije ustanovljena.
English: Antibacterial activity in combination with other antibacterial agents
Croatian: Antibakterijska aktivnost u kombinaciji s drugim antibakterijskim lijekovima
English: Zavicefta is administered by intravenous infusion over 120 minutes in an infusion volume of 100 mL.
Croatian: Zavicefta se primjenjuje intravenskom infuzijom tijekom 120 minuta u infuzijskom volumenu od 100 ml.
English: No metabolism of avibactam was observed in human liver preparations (microsomes and hepatocytes).
Croatian: Nije primijećen metabolizam avibaktama u preparatima ljudske jetre (mikrosomi i hepatociti).
English: The marketing authorisation holder shall submit the first periodic safety update report for this product within 6 months following authorisation.
Croatian: Nositelj odobrenja za stavljanje lijeka u promet će prvo periodičko izvješće o neškodljivosti za ovaj lijek dostaviti unutar 6 mjeseci nakon dobivanja odobrenja.
English: This is because it is not known if the medicine is safe to use in these age groups.
Croatian: Naime, nije poznato je li primjena tog lijeka sigurna u tim dobnim skupinama.
English: It is available in packs containing 10 vials.
Croatian: Dostupan je u pakiranjima koja sadrže 10 bočica.
English: • you are allergic to ceftazidime, avibactam or any of the other ingredients of this medicine (listed in section 6)
Croatian: • ako ste alergični na ceftazidim, avibaktam ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.)
English: From a microbiological point of view, the medicinal product should be used immediately unless reconstitution and dilution has taken place in controlled and validated aseptic conditions.
Croatian: S mikrobiološkog stanovišta, lijek se mora odmah primijeniti, osim ako rekonstitucija i razrjeđivanje nisu provedeni u kontroliranim i validiranim aseptičkim uvjetima.
English: Alternatively they are stable for up to 24 hours under refrigerated storage.
Croatian: Osim toga, stabilna je do najviše 24 sata ako se čuva u hladnjaku.
English: Medicinal products that inhibit peristalsis should not be given.
Croatian: Ne smiju se primjenjivati lijekovi koji inhibiraju peristaltiku.
English: In case of hypersensitivity reactions, treatment with Zavicefta must be discontinued immediately and adequate emergency measures must be initiated.
Croatian: U slučaju reakcija preosjetljivosti liječenje lijekom Zavicefta mora se odmah prekinuti i moraju se započeti odgovarajuće mjere hitnog liječenja.
English: How Zavicefta works Zavicefta works by killing certain types of bacteria, which can cause serious infections.
Croatian: Kako Zavicefta djeluje Zavicefta djeluje tako da ubija određene vrste bakterija koje mogu uzrokovati ozbiljne infekcije.
English: Common (≥1/100 and <1/10) Uncommon (≥1/1,000 and <1/100) Rare (≥1/10,000 and <1/1000) Very rare (<1/10,000)
Croatian: vrlo često (≥ 1/10) često (≥ 1/100 i < 1/10) manje često (≥ 1/1000 i < 1/100)
English: Studies have shown that Zavicefta solutions for infusion are stable for up to 12 hours at room temperature.
Croatian: Ispitivanja su pokazala da je otopina lijeka Zavicefta za infuziju stabilna do najviše 12 sati na sobnoj temperaturi.
English: During a 4-hour haemodialysis period, 55% of the avibactam dose was removed.
Croatian: Tijekom hemodijalize u trajanju od 4 sata uklonjeno je 55% doze avibaktama.
English: Discontinuation of therapy with Zavicefta and the administration of specific treatment for Clostridium difficile should be considered.
Croatian: Treba razmotriti prekid terapije lijekom Zavicefta i primjenu specifičnog liječenja za Clostridium difficile.
English: Unknown
Croatian: Nepoznato